Patents Assigned to Sanofi-Arentideutschland GmbH
  • Immunoglobulin fusion proteins, their production and use
    Patent number: 7253264
    Abstract: The invention relates to genetically engineered soluble fusion proteins composed of human proteins not belonging to the immunoglobulin family, or of parts thereof, and of various portions of the constant region of immunoglobulin molecules. The functional properties of the two fusion partners are surprisingly retained in the fusion protein.
    Type: Grant
    Filed: August 22, 1994
    Date of Patent: August 7, 2007
    Assignees: Sanofi-Arentideutschland GmbH, The General Hospital Corporation
    Inventors: Leander Lauffer, Gerd Zettlmeissl, Patricia Oquendo, Brian Seed